Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel
H Döhner, E Estey, D Grimwade… - Blood, The Journal …, 2017 - ashpublications.org
The first edition of the European LeukemiaNet (ELN) recommendations for diagnosis and
management of acute myeloid leukemia (AML) in adults, published in 2010, has found …
management of acute myeloid leukemia (AML) in adults, published in 2010, has found …
European LeukemiaNet recommendations for the management of chronic myeloid leukemia: 2013
M Baccarani, MW Deininger, G Rosti… - Blood, The Journal …, 2013 - ashpublications.org
Advances in chronic myeloid leukemia treatment, particularly regarding tyrosine kinase
inhibitors, mandate regular updating of concepts and management. A European …
inhibitors, mandate regular updating of concepts and management. A European …
One and a half million hematopoietic stem cell transplants: continuous and differential improvement in worldwide access with the use of non-identical family donors
D Niederwieser, H Baldomero, N Bazuaye… - …, 2021 - pmc.ncbi.nlm.nih.gov
The Worldwide Network of Blood and Marrow Transplantation (WBMT) pursues the mission
of promoting hematopoietic cell transplantation (HCT) for instance by evaluating activities …
of promoting hematopoietic cell transplantation (HCT) for instance by evaluating activities …
Early cytomegalovirus reactivation remains associated with increased transplant-related mortality in the current era: a CIBMTR analysis
P Teira, M Battiwalla, M Ramanathan… - Blood, The Journal …, 2016 - ashpublications.org
Single-center studies have reported an association between early (before day 100)
cytomegalovirus (CMV) reactivation and decreased incidence of relapse for acute myeloid …
cytomegalovirus (CMV) reactivation and decreased incidence of relapse for acute myeloid …
Indications for allo-and auto-SCT for haematological diseases, solid tumours and immune disorders: current practice in Europe, 2015
This is the sixth special report that the European Society for Blood and Marrow
Transplantation regularly publishes on the current practice and indications for …
Transplantation regularly publishes on the current practice and indications for …
Competing risks in epidemiology: possibilities and pitfalls
PK Andersen, RB Geskus, T de Witte… - International journal of …, 2012 - academic.oup.com
Background In studies of all-cause mortality, the fundamental epidemiological concepts of
rate and risk are connected through a well-defined one-to-one relation. An important …
rate and risk are connected through a well-defined one-to-one relation. An important …
Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet
H Döhner, EH Estey, S Amadori… - Blood, The Journal …, 2010 - ashpublications.org
In 2003, an international working group last reported on recommendations for diagnosis,
response assessment, and treatment outcomes in acute myeloid leukemia (AML). Since that …
response assessment, and treatment outcomes in acute myeloid leukemia (AML). Since that …
Comorbidity-age index: a clinical measure of biologic age before allogeneic hematopoietic cell transplantation
ML Sorror, RF Storb, BM Sandmaier… - Journal of Clinical …, 2014 - ascopubs.org
Purpose Age has long been used as a major factor for assessing suitability for allogeneic
hematopoietic cell transplantation (HCT). The HCT-comorbidity index (HCT-CI) was …
hematopoietic cell transplantation (HCT). The HCT-comorbidity index (HCT-CI) was …
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT
We previously reported that the Charlson Comorbidity Index (CCI) was useful for predicting
outcomes in patients undergoing allogeneic hematopoietic cell transplantation (HCT) …
outcomes in patients undergoing allogeneic hematopoietic cell transplantation (HCT) …
Chronic myeloid leukemia: an update of concepts and management recommendations of European LeukemiaNet
Purpose To review and update the European LeukemiaNet (ELN) recommendations for the
management of chronic myeloid leukemia with imatinib and second-generation tyrosine …
management of chronic myeloid leukemia with imatinib and second-generation tyrosine …